MED ALL SOLUTION: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MED ALL SOLUTION
Largest movements
No asset line moved by more than 1% of the balance sheet total.
- Profit (loss) carried forward -€869
down €869 (-0.3%), from -€267,185 to -€268,054
- Trade debts +€717
up €717 (+6.7%), from €10,643 to €11,360
- Financial charges -€1,439
no longer reported in 2025 (was €1,439)
of which Non-recurring financial charges: -€1,000
- Gross operating margin -€130
new in 2025: -€130
- Other operating charges -€7
down €7 (-1.8%), from €394 to €387
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €19,215 | €19,201 | -€13 | -0.1% |
| Current assets | 29/58 | €19,215 | €19,201 | -€13 | -0.1% |
| Amounts receivable within one year | 40/41 | €19,101 | €19,101 | = | 0.0% |
| Trade receivables | 40 | €18,362 | €18,362 | = | 0.0% |
| Other amounts receivable | 41 | €739 | €739 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €113 | €100 | -€13 | -11.6% |
| Total equity and liabilities | 10/49 | €19,215 | €19,201 | -€13 | -0.1% |
| Equity | 10/15 | -€204,185 | -€205,054 | -€869 | -0.4% |
| Contributions | 10/11 | €63,000 | €63,000 | = | 0.0% |
| Capital | 10 | €63,000 | €63,000 | = | 0.0% |
| Issued capital | 100 | €63,000 | €63,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€267,185 | -€268,054 | -€869 | -0.3% |
| Amounts payable | 17/49 | €223,399 | €224,256 | +€856 | +0.4% |
| Amounts payable within one year | 42/48 | €223,164 | €223,893 | +€729 | +0.3% |
| Current portion of amounts payable after more than one year | 42 | - | €12 | +€12 | |
| Financial debts | 43 | €199,821 | €199,821 | = | 0.0% |
| Other loans | 439 | €199,821 | €199,821 | = | 0.0% |
| Trade debts | 44 | €10,643 | €11,360 | +€717 | +6.7% |
| Suppliers | 440/4 | €10,643 | €11,360 | +€717 | +6.7% |
| Other amounts payable | 47/48 | €12,700 | €12,700 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €236 | €363 | +€127 | +53.8% |
| Other operating charges | 640/8 | €394 | €387 | -€7 | -1.8% |
| Non-recurring operating charges | 66A | €91,306 | €352 | -€90,953 | -99.6% |
| Gross operating margin | 9900 | - | -€130 | -€130 | |
| Operating profit (loss) | 9901 | -€91,700 | -€869 | +€90,831 | +99.1% |
| Financial charges | 65/66B | €1,439 | - | -€1,439 | |
| Recurring financial charges | 65 | €439 | - | -€439 | |
| Non-recurring financial charges | 66B | €1,000 | - | -€1,000 | |
| Profit (loss) for the period before taxes | 9903 | -€93,139 | -€869 | +€92,270 | +99.1% |
| Profit (loss) for the period | 9904 | -€93,139 | -€869 | +€92,270 | +99.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€93,139 | -€869 | +€92,270 | +99.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.